☆ 4.6 Article

BNT162b2 mRNA COVID-19 Vaccine Effectiveness in Patients with Coeliac Disease Autoimmunity: Real-World Data from Mass Vaccination Campaign

VIRUSES-BASEL (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Gastroenterology & Hepatology

Humoral immunogenicity of COVID-19 vaccines in patients with coeliac disease and other noncoeliac enteropathies compared to healthy controls

Davide Scalvini et al.

Summary: The immunogenicity of SARS-CoV-2 vaccines was not reduced in patients with coeliac disease compared to controls, while it was impaired in patients with Whipple's disease and common-variable immunodeficiency (CVID). Post-vaccination humoral response should be monitored in patients with Whipple's disease and chronic enteropathies on immunosuppressive therapy in order to schedule vaccine booster doses.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Immune responses to SARS-CoV-2 vaccines in celiac disease

Jostein H. Ibsen et al.

Summary: This study investigated the humoral response to SARS-CoV-2 vaccines in patients with celiac disease (CeD) and compared it with healthy controls. The results showed that the humoral response in CeD patients is similar to that observed in healthy controls.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2023)

添加到收藏夹

Review Gastroenterology & Hepatology

COVID-19 and celiac disease: a review

Brandon S. Cohen et al.

Summary: This review summarizes the impact of the COVID-19 pandemic on individuals with celiac disease, including perceived risk, risk of infection or severe illness, vaccination considerations, access to gluten-free food, and potential long-term changes to celiac disease management. Studies have shown that individuals with celiac disease are not at an increased risk of contracting or having a severe course of COVID-19. There is currently no evidence to suggest that COVID-19 infection leads to an increase in celiac disease incidence. However, telemedicine has become more prevalent and may provide improved access to healthcare for celiac disease patients in the long term. Overall, individuals with celiac disease do not appear to be at an increased risk of COVID-19 infection or severe illness.

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2023)

添加到收藏夹

Article Immunology

The Effectiveness of the Two-Dose BNT162b2 Vaccine: Analysis of Real-World Data

Gabriel Chodick et al.

Summary: The study evaluated the real-world effectiveness of the BNT162b2 vaccine in Israel, showing a significantly reduced incidence of infection during the protection period compared to the reference period. The vaccine demonstrated 90% effectiveness in preventing infection and 94% effectiveness against COVID-19, with lower efficacy observed in immunosuppressed elderly individuals.

CLINICAL INFECTIOUS DISEASES (2022)

添加到收藏夹

Article Immunology

Humoral immune response to COVID-19 infection or vaccination among celiac disease patients

Eman Albatayneh et al.

Summary: This study measured the levels of IgG antibodies in Jordanian patients with celiac disease who were infected with or vaccinated against the SARS-CoV-2 virus. The results showed that celiac disease patients had lower levels of SARS-CoV-2 antibodies compared to controls, and celiac disease patients who received the Pfizer vaccine had higher IgG levels than those who received the AstraZeneca vaccine.

CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY (2022)

添加到收藏夹

Review Gastroenterology & Hepatology

Epidemiology, Presentation, and Diagnosis of Celiac Disease

Benjamin Lebwohl et al.

Summary: The incidence of celiac disease is increasing due to both improved recognition and a real increase of the disorder. The reasons for this true rise are unclear, but may be related to environmental factors. Early-life gluten exposure is a major focus of prevention efforts.

GASTROENTEROLOGY (2021)

添加到收藏夹

Review Immunology

COVID-19: A review of therapeutic strategies and vaccine candidates

Vladislav Izda et al.

Summary: The COVID-19 pandemic has become a major global public health crisis, prompting urgent efforts in the scientific community to search for therapeutic and preventative solutions, including the development of pharmacological therapies and vaccines. This article aims to review the latest data on pharmacological therapies undergoing clinical trials and vaccine candidates in development to combat COVID-19.

CLINICAL IMMUNOLOGY (2021)

添加到收藏夹

Editorial Material Gastroenterology & Hepatology

COVID-19 Vaccination Is Safe and Effective in Patients With Inflammatory Bowel Disease: Analysis of a Large Multi-institutional Research Network in the United States

Yousaf Bashir Hadi et al.

GASTROENTEROLOGY (2021)

添加到收藏夹

Article Immunology

Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups

Clodoveo Ferri et al.

Summary: This study found significantly lower NAbs levels and higher percentage of non-responders to COVID-19 vaccines among ASD patients. Early determination of serum NAb and prioritizing booster doses or different types of vaccines based on individual responses are recommended.

JOURNAL OF AUTOIMMUNITY (2021)

添加到收藏夹

Article Medicine, General & Internal

Waning Immunity after the BNT162b2 Vaccine in Israel

Yair Goldberg et al.

Summary: The immunity against the delta variant of SARS-CoV-2 waned in all age groups in Israel a few months after receiving the second dose of the vaccine, leading to an increase in infection and severe cases.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

Noa Dagan et al.

Summary: A study conducted in Israel on nearly 600,000 individuals showed that the BNT162b2 mRNA vaccine was effective in reducing the risk of infection, hospitalization, and severe Covid-19. The effectiveness in preventing death was 72% during the period from day 14 through day 20 after the first dose, and hospitalization was reduced by 87% for the period 7 or more days after the second dose, similar to results from a randomized trial.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health

Risk of Severe Covid-19 in Patients with Celiac Disease: A Population-Based Cohort Study

Benjamin Lebwohl et al.

Summary: In this population-based study in Sweden, there was no significant association found between celiac disease and severe outcomes related to Covid-19. Celiac disease did not increase the risk of hospitalization for Covid-19 or severe disease, even after adjusting for comorbidities.

CLINICAL EPIDEMIOLOGY (2021)

添加到收藏夹

Article Nutrition & Dietetics

Health-Related Quality of Life and Experiences of Brazilian Celiac Individuals over the Course of the Sars-Cov-2 Pandemic

Ana Luisa Falcomer et al.

Summary: The study revealed that during the COVID-19 pandemic, the quality of life (QoL) of Brazilian individuals with celiac disease (CD) was more affected by gastrointestinal aspects, but overall the pandemic did not have a negative impact on their QoL. Individuals not following a gluten-free diet and those using antidepressants experienced a larger burden and diminished QoL. Further research is needed to understand how the duration of the pandemic will affect celiac individuals and compare outcomes to periods before and after COVID-19.

NUTRIENTS (2021)

添加到收藏夹

Letter Gastroenterology & Hepatology

BNT162b2 Messenger RNA COVID-19 Vaccine Effectiveness in Patients With Inflammatory Bowel Disease: Preliminary Real-World Data During Mass Vaccination Campaign

Amir Ben-Tov et al.

GASTROENTEROLOGY (2021)

添加到收藏夹

Article Cell Biology

BNT162b2 vaccination effectively prevents the rapid rise of SARS-CoV-2 variant B.1.1.7 in high-risk populations in Israel

Ariel Munitz et al.

Summary: Research shows that the B.1.1.7 variant is 45% more transmissible than the wild-type strain and has become the dominant strain in Israel within 3.5 weeks. Despite this, targeted RT-PCR testing and prioritized vaccination programs are still capable of preventing its spread in the elderly population. Therefore, proactive surveillance programs and prioritized vaccination can effectively reduce the occurrence of severe illness and death.

CELL REPORTS MEDICINE (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Accuracy of a no-biopsy approach for the diagnosis of coeliac disease across different adult

Hugo A. Penny et al.

Summary: The study aimed to determine the predictive capacity and diagnostic yield of a 10-fold increase in serum IgA antitissue transglutaminase (tTG) antibody levels for detecting small intestinal injury diagnostic of coeliac disease (CD) in adult patients. Results showed that IgA tTG levels of >= 10xULN have a strong predictive value at identifying adults with intestinal changes diagnostic of CD, supporting the use of a no-biopsy approach for the diagnosis of adult CD.

GUT (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Increased incidence of coeliac disease autoimmunity rate in Israel: a 9-year analysis of population-based data

Niva Lechtman et al.

Summary: The study showed a steady increase in the incidence of coeliac disease autoimmunity in Israel between 2007 and 2015, with children being the main contributors to this trend.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

European Society Paediatric Gastroenterology, Hepatology and Nutrition Guidelines for Diagnosing Coeliac Disease 2020

Steffen Husby et al.

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2020)

添加到收藏夹

Review Gastroenterology & Hepatology

Incidence of Celiac Disease Is Increasing Over Time: A Systematic Review and Meta-analysis

James A. King et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)

添加到收藏夹

Review Immunology

Vaccinations and Immune Response in Celiac Disease

Stefano Passanisi et al.

VACCINES (2020)

添加到收藏夹

Article Gastroenterology & Hepatology

European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders

Abdulbaqi Al-Toma et al.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2019)

添加到收藏夹

Review Gastroenterology & Hepatology

AGA Clinical Practice Update on Diagnosis and Monitoring of Celiac Disease-Changing Utility of Serology and Histologic Measures: Expert Review

Steffen Husby et al.

GASTROENTEROLOGY (2019)

添加到收藏夹

Review Medicine, General & Internal

Celiac Disease and Increased Risk of Pneumococcal Infection: A Systematic Review and Meta-Analysis

Malorie Simons et al.

AMERICAN JOURNAL OF MEDICINE (2018)

添加到收藏夹

Article Gastroenterology & Hepatology

Accuracy in Diagnosis of Celiac Disease Without Biopsies in Clinical Practice

Katharina Julia Werkstetter et al.

GASTROENTEROLOGY (2017)

添加到收藏夹

Article Medicine, General & Internal

Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and Mortality

Josef Coresh et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

The use of an automated patient registry to manage and monitor cardiovascular conditions and related outcomes in a large health organization

Varda Shalev et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2011)

添加到收藏夹

Article Gastroenterology & Hepatology

Failure to respond to hepatitis B vaccine in children with Celiac disease

Seung-Dae Park et al.

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2007)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.